300 related articles for article (PubMed ID: 13130488)
1. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653.
Nishikawa M; Myoui A; Tomita T; Takahi K; Nampei A; Yoshikawa H
Arthritis Rheum; 2003 Sep; 48(9):2670-81. PubMed ID: 13130488
[TBL] [Abstract][Full Text] [Related]
2. [p38 MAP Kinase inhibitor].
Nishikawa M; Myoui A; Tomita T; Takahi K; Nampei A; Yoshikawa H
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Oct; 30(5):390-7. PubMed ID: 17984579
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
[TBL] [Abstract][Full Text] [Related]
4. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.
Matsumoto M; Sudo T; Maruyama M; Osada H; Tsujimoto M
FEBS Lett; 2000 Dec; 486(1):23-8. PubMed ID: 11108836
[TBL] [Abstract][Full Text] [Related]
5. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.
Tao H; Okamoto M; Nishikawa M; Yoshikawa H; Myoui A
PLoS One; 2011; 6(8):e23199. PubMed ID: 21886782
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. FR167653 attenuates ischemia and reperfusion injury of the rat lung with suppressing p38 mitogen-activated protein kinase.
Kawashima Y; Takeyoshi I; Otani Y; Koibuchi Y; Yoshinari D; Koyama T; Kobayashi M; Matsumoto K; Morishita Y
J Heart Lung Transplant; 2001 May; 20(5):568-74. PubMed ID: 11343984
[TBL] [Abstract][Full Text] [Related]
8. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.
Badger AM; Griswold DE; Kapadia R; Blake S; Swift BA; Hoffman SJ; Stroup GB; Webb E; Rieman DJ; Gowen M; Boehm JC; Adams JL; Lee JC
Arthritis Rheum; 2000 Jan; 43(1):175-83. PubMed ID: 10643714
[TBL] [Abstract][Full Text] [Related]
9. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.
Yoshinari D; Takeyoshi I; Koibuchi Y; Matsumoto K; Kawashima Y; Koyama T; Ohwada S; Morishita Y
Crit Care Med; 2001 Mar; 29(3):628-34. PubMed ID: 11373433
[TBL] [Abstract][Full Text] [Related]
10. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA).
Ando W; Hashimoto J; Nampei A; Tsuboi H; Tateishi K; Ono T; Nakamura N; Ochi T; Yoshikawa H
J Bone Miner Metab; 2006; 24(4):274-82. PubMed ID: 16816921
[TBL] [Abstract][Full Text] [Related]
12. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of FR167653, an inhibitor of p38 mitogen-activated kinase, on calreticulin mRNA expression induced by endoplasmic reticulum stresses.
Yamazaki T; Muramoto M; Nishimura S; Kita Y
Eur J Pharmacol; 2004 Jan; 484(2-3):147-56. PubMed ID: 14744598
[TBL] [Abstract][Full Text] [Related]
14. p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages.
Li X; Udagawa N; Takami M; Sato N; Kobayashi Y; Takahashi N
Endocrinology; 2003 Nov; 144(11):4999-5005. PubMed ID: 12960069
[TBL] [Abstract][Full Text] [Related]
15. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
Huber DM; Bendixen AC; Pathrose P; Srivastava S; Dienger KM; Shevde NK; Pike JW
Endocrinology; 2001 Sep; 142(9):3800-8. PubMed ID: 11517156
[TBL] [Abstract][Full Text] [Related]
16. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
[TBL] [Abstract][Full Text] [Related]
19. FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils.
Takahashi S; Keto Y; Fujita T; Uchiyama T; Yamamoto A
J Pharmacol Exp Ther; 2001 Jan; 296(1):48-56. PubMed ID: 11123361
[TBL] [Abstract][Full Text] [Related]
20. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
